Medtronic plc (ETR: 2M6)
Market Cap | 102.64B |
Revenue (ttm) | 30.01B |
Net Income (ttm) | 3.62B |
Shares Out | n/a |
EPS (ttm) | 2.73 |
PE Ratio | n/a |
Forward PE | n/a |
Dividend | n/a |
Ex-Dividend Date | Sep 27, 2024 |
Volume | 1,088 |
Open | 81.20 |
Previous Close | 80.55 |
Day's Range | 79.47 - 81.20 |
52-Week Range | 65.00 - 83.10 |
Beta | n/a |
Analysts | n/a |
Price Target | n/a |
Earnings Date | Nov 19, 2024 |
About Medtronic
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accesso... [Read more]
Financial Performance
In 2024, Medtronic's revenue was $32.36 billion, an increase of 3.64% compared to the previous year's $31.23 billion. Earnings were $3.68 billion, a decrease of -2.18%.
Financial numbers in USD Financial StatementsNews
Medtronic: This Dividend Aristocrat Is Still A Buy Now
Medtronic expands AiBLE™ spine surgery ecosystem with new technologies and Siemens Healthineers partnership
GALWAY, Ireland and CHICAGO , Sept. 25, 2024 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, announced today at the North American Spine Society (NASS) 39th Annual...
Intuitive Surgical Offers Low Risk, High Return Despite Valuation Concerns
Intuitive Surgical remains a leader in robotic surgery despite intensifying competition from Medtronic and Johnson & Johnson. Read why ISRG stock is a Buy.
Medtronic Unusual Options Activity For September 23
Investors with a lot of money to spend have taken a bearish stance on Medtronic (NYSE: MDT). And retail traders should know. We noticed this today when the positions showed up on publicly available o...
Going Ex-Dividend
Just over a tenth of the stocks in the S&P 500 are going ex-dividend in the next two weeks. If the ex-dividend date is 9/20/24, for example, you'd need to own shares as of the close on 9/19/24 to capt...
Axonics Prevails in Patent Infringement Lawsuit with Medtronic
Axonics, Inc. (Nasdaq: AXNX) today announced that the jury has returned a unanimous verdict in the patent infringement lawsuit brought by Medtronic against Axonics in U.S. District Court for the Centr...
Axonics gains after win in trial in patent dispute with Medtronic
Axonics Inc. (AXNX) comes out victorious in a patent trial against Medtronic (MDT), as jury rules in its favor, awarding Medtronic nothing.
Tommy Tuberville sells Apple, UPS, CVS, Medtronic in new disclosure
A new trading form filed by Senator Tommy Tuberville disclosed that he sold shares in tech giant Apple (AAPL), along with several other companies. Read for more.
Medtronic: An Undervalued Stock With Durable Competitive Advantages
Swift Medical Selected for Consortium to Advance Pressure Injury Prevention with AI
Swift Medical’s wound care experience and market-leading penetration were a catalyst for invitation to the PressureSmart consortium led by Medtronic. TORONTO — Award-winning Swift Medical brings deep ...
3 Reasons Medtronic's Stock Can Continue Rallying Higher
Medtronic's stock has been rising higher in recent weeks after another solid quarterly performance.
3M, Visa, Medtronic And More On CNBC's 'Final Trades'
On CNBC's “ Halftime Report Final Trades ,” Joshua Brown of Ritholtz Wealth Management named 3M Company (NYSE: MMM), which recorded gains on Tuesday . On Sept. 6, Morgan Stanley analyst Chris Snyder ...
Final Trades: 3M, Visa, Medtronic and the SPHD
The Investment Committee give you their top stocks to watch for the second half.
Final Trades: 3M, Visa, Medtronic and the SPHD
The Investment Committee give you their top stocks to watch for the second half.
Medtronic CEO goes one-on-one with Jim Cramer
Geoff Martha, Medtronic chairman and CEO, joins 'Mad Money' host Jim Cramer to talk quarterly results, utilizing AI in healthcare, and more.
Health care stocks are outperforming and one name is flashing a rare buy signal, according to the charts
David Keller uncovered a possible breakout candidate in Medtronic.
Billionaire Ray Dalio's Former Hedge Fund Is Buying These 3 Top Dividend Stocks. Should You?
Bridgewater Associates is loading up on shares of ExxonMobil, Medtronic, and Microsoft. Here's what you need to know.
Medtronic plc (MDT) 2024 Wells Fargo Healthcare Conference
Medtronic plc (MDT) 2024 Wells Fargo Healthcare Conference
Is Medtronic Stock a Buy?
It might not be the most exciting business, but it has other things going its way.
Medtronic chairman and CEO Geoff Martha to speak at the Wells Fargo Healthcare Conference
GALWAY, Ireland , Aug. 27, 2024 /PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced it will participate in the 2024 Wells Fargo Healthcare Conference on...
PaceMate® Acquires Medtronic Paceart Optima™ System, Bringing Complementary Capabilities to Cardiac Data Management
SARASOTA, Fla.--(BUSINESS WIRE)--PaceMate®, a pioneer in cardiac data management and remote monitoring, announced today the acquisition of the Paceart Optima™ system, an on-premises cardiac workflow s...
Medtronic: Is The Company Back?
Medtronic has solid competitive advantages and a promising dividend streak. Read what makes MDT stock a long-term buy for conservative investors.
Medtronic: Is The Company Back?
Medtronic has solid competitive advantages and a promising dividend streak. Read what makes MDT stock a long-term buy for conservative investors.
Medtronic snaps seven straight sessions of gains
Medtronic (MDT) stock shows steady growth, up 9.48% in the past week.